Levothyroxine in Women with Thyroid Peroxidase Antibodies before Conception
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Thyroid peroxidase antibodies are associated with an increased risk of miscarriage and preterm birth, even when thyroid function is normal. Small trials indicate that the use of levothyroxine could reduce the incidence of such adverse outcomes. METHODS: We conducted a double-blind, placebo-controlled trial to investigate whether levothyroxine treatment would increase live-birth rates among euthyroid women who had thyroid peroxidase antibodies and a history of miscarriage or infertility. A total of 19,585 women from 49 hospitals in the United Kingdom underwent testing for thyroid peroxidase antibodies and thyroid function. We randomly assigned 952 women to receive either 50 μg once daily of levothyroxine (476 women) or placebo (476 women) before conception through the end of pregnancy. The primary outcome was live birth after at least 34 weeks of gestation. RESULTS: The follow-up rate for the primary outcome was 98.7% (940 of 952 women). A total of 266 of 470 women in the levothyroxine group (56.6%) and 274 of 470 women in the placebo group (58.3%) became pregnant. The live-birth rate was 37.4% (176 of 470 women) in the levothyroxine group and 37.9% (178 of 470 women) in the placebo group (relative risk, 0.97; 95% confidence interval [CI], 0.83 to 1.14, P = 0.74; absolute difference, -0.4 percentage points; 95% CI, -6.6 to 5.8). There were no significant between-group differences in other pregnancy outcomes, including pregnancy loss or preterm birth, or in neonatal outcomes. Serious adverse events occurred in 5.9% of women in the levothyroxine group and 3.8% in the placebo group (P = 0.14). CONCLUSIONS: The use of levothyroxine in euthyroid women with thyroid peroxidase antibodies did not result in a higher rate of live births than placebo. (Funded by the United Kingdom National Institute for Health Research; TABLET Current Controlled Trials number, ISRCTN15948785.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, there were insufficient data to perform a subgroup analysis of women with recurrent miscarriage, TPO antibodies and SCH.192”
From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [192]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alexander, E. K., Pearce, E. N., Brent, G. A., Brown, R. S., Chen, H., Dosiou, C., Grobman, W. A., Laurberg, P., Lazarus, J. H., Mandel, S. J., et al. (2017) · Thyroid® · doi:10.1089/thy.2016.0457 · Cited by 2,731
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.220 · Cited by 2,294
Negro, R., Formoso, G., Mangieri, T., Pezzarossa, A., Dazzi, D., & Hassan, H. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1603 · Cited by 759
Thangaratinam, S., Tan, A., Knox, E., Kilby, M. D., Franklyn, J., & Coomarasamy, A. (2011) · BMJ · doi:10.1136/bmj.d2616 · Cited by 604
Self-citationWang, H., Gao, H., Chi, H., Zeng, L., Xiao, W., Wang, Y., Li, R., Liu, P., Wang, C., Tian, Q., et al. (2017) · JAMA · doi:10.1001/jama.2017.18249 · Cited by 236
Negro, R., Mangieri, T., Coppola, L., Presicce, G., Casavola, E. C., Gismondi, R., Locorotondo, G., Caroli, P., Pezzarossa, A., Dazzi, D., et al. (2005) · Human Reproduction · doi:10.1093/humrep/deh843 · Cited by 233
Research works printed but not linked: 1
- Fertility problems: assessment and treatment. NICE clinical guideline 156. London: National Institute for Health and Care Excellence, 2013.
Cited by
Dimitriadis, E., Menkhorst, E., Saito, S., Kutteh, W. H., & Brosens, J. J. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00228-z · Cited by 702
The Consortium on Thyroid and Pregnancy—Study Group on Preterm Birth, Korevaar, T. I. M., Derakhshan, A., Taylor, P. N., Meima, M., Chen, L., Bliddal, S., Carty, D. M., Meems, M., Vaidya, B., et al. (2019) · JAMA · doi:10.1001/jama.2019.10931 · Cited by 378
Derakhshan, A., Peeters, R. P., Taylor, P. N., Bliddal, S., Carty, D. M., Meems, M., Vaidya, B., Chen, L., Knight, B. A., Ghafoor, F., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30061-9 · Cited by 251
Assessment and treatment of thyroid disorders in pregnancy and the postpartum period
Lee, S. Y., & Pearce, E. N. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00604-z · Cited by 206
Thyroid Disease in Pregnancy: ACOG Practice Bulletin, Number 223
(2020) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003893 · Cited by 212
Poppe, K., Bisschop, P., Fugazzola, L., Minziori, G., Unuane, D., & Weghofer, A. (2020) · European Thyroid Journal · doi:10.1159/000512790 · Cited by 196
Turesheva, A., Aimagambetova, G., Ukybassova, T., Marat, A., Kanabekova, P., Kaldygulova, L., Amanzholkyzy, A., Ryzhkova, S., Nogay, A., Khamidullina, Z., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12124074 · Cited by 174
The Thyroid Hormone Axis and Female Reproduction
Brown, E. D. L., Obeng-Gyasi, B., Hall, J. E., & Shekhar, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129815 · Cited by 232
Recurrent miscarriage: evidence to accelerate action
Coomarasamy, A., Dhillon-Smith, R. K., Papadopoulou, A., Al-Memar, M., Brewin, J., Abrahams, V. M., Maheshwari, A., Christiansen, O. B., Stephenson, M. D., Goddijn, M., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00681-4 · Cited by 180
Self-citationRecurrent MiscarriageGreen‐top Guideline No. 17
Regan, L., Rai, R., Saravelos, S., Li, T., & the Royal College of Obstetricians and Gynaecologists (2023) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17515 · Cited by 158
Self-citationRecent Advances in Treatment of Recurrent Spontaneous Abortion
Deng, T., Liao, X., & Zhu, S. (2022) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000001033 · Cited by 153
“Another group of studies showed that LT4 did not improve pregnancy outcomes in TPOAb-positive women with normal thyroid function.(61) As there is insufficient evidence of efficacy or harm, existing guidelines do not recommend or oppose intervention.”
ResultGhafourian, M., Mahdavi, R., Jonoush, Z. A., Sadeghi, M., Ghadiri, N., Farzaneh, M., & Salehi, A. M. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00853-z · Cited by 141
Taylor, P. N., Medici, M. M., Hubalewska-Dydejczyk, A., & Boelaert, K. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01614-3 · Cited by 128
Self-citationSheikh, J., Allotey, J., Kew, T., Fernández-Félix, B. M., Zamora, J., Khalil, A., Thangaratinam, S., Abdollahain, M., Savitri, A. I., Salvesen, K. Å., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01191-6 · Cited by 108
Self-citationDong, A. C., Morgan, J. C., Kane, M., Stagnaro‐Green, A., & Stephenson, M. D. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.11.003 · Cited by 120
van Dijk, M. M., Vissenberg, R., Fliers, E., van der Post, J., van der Hoorn, M., de Weerd, S., Kuchenbecker, W. K., Hoek, A., Sikkema, J. M., Verhoeve, H. R., et al. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00045-6 · Cited by 114
MANAGEMENT OF ENDOCRINE DISEASE: Thyroid and female infertility: more questions than answers?!
Poppe, K. G. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1284 · Cited by 108
Thyroid Autoimmunity in Female Infertility and Assisted Reproductive Technology Outcome
Bucci, I., Giuliani, C., Dalmazi, G. D., Formoso, G., & Napolitano, G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.768363 · Cited by 113
Quenby, S. M., Booth, K., Hiller, L., Coomarasamy, A., de Jong, P. G., Hamulyák, E. N., Scheres, L. J. J., van Haaps, T. F., Ewington, L. J., Tewary, S., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00693-1 · Cited by 100
Self-citationAutoimmune Thyroid Disease in Women
Mammen, J. S., & Cappola, A. R. (2021) · JAMA · doi:10.1001/jama.2020.22196 · Cited by 108
Thyroid autoimmunity and its negative impact on female fertility and maternal pregnancy outcomes
Tańska, K., Gietka‐Czernel, M., Glinicki, P., & Kozakowski, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1049665 · Cited by 105
“2019, United Kingdom (89) Treated group n = 476 Placebo group n = 476 Women with history of miscarriage and/or infertility TPOAb LT4 instituted before conception at a fixed dose of 50 μg/ day and maintained throughout pregnancy No difference between LT4 and placebo groups in the rates of: live birth 37.”
BackgroundThyroid and Fertility: Recent Advances
Dosiou, C. (2020) · Thyroid · doi:10.1089/thy.2019.0382 · Cited by 92
“The second RCT is the much anticipated Thyroid Anti-bodies and Levothyroxine (TABLET) trial, a multicenter study of 940 women in the United Kingdom, which evaluated the effect of levothyroxine on live births in euthyroid anti-TPO Ab-positive women with a history of infertility or miscarriage (21).”
InfluentialImpact of thyroid disease on fertility and assisted conception
Unuane, D., & Velkeniers, B. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101378 · Cited by 113
The role of thyroid function in female and male infertility: a narrative review
Mazzilli, R., Medenica, S., Tommaso, A. M. D., Fabozzi, G., Zamponi, V., Cimadomo, D., Rienzi, L. F., Ubaldi, F. M., Watanabe, M., Faggiano, A., et al. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01883-7 · Cited by 102
“Two randomized studies showed a significant reduction in miscarriages with levothyroxine treatment [83, 84], while one other, very large, did not find any significant difference in live birth rates upon treatment with a fixed dose of 50 mcg levothyroxine started before pregnancy [85].”
Bein, M., Yu, O. H. Y., Grandi, S. M., Frati, F. Y. E., Kandil, I., & Filion, K. B. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00699-5 · Cited by 90
“In contrast, two recent RCTs found that levothyroxine treatment of TPOAb positive women who had normal thyroid function during pregnancy did not affect pregnancy outcomes [56, 57].”
ResultTPO antibody positivity and adverse pregnancy outcomes
Dhillon‐Smith, R. K., & Coomarasamy, A. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101433 · Cited by 95
Self-citationThyroid autoimmunity and IVF/ICSI outcomes in euthyroid women: a systematic review and meta-analysis
Venables, A., Wong, W., Way, M., & Homer, H. A. (2020) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-020-00671-3 · Cited by 82
“The recently reported TABLET trial [37] studied a broader population of TAI+ women with a history of miscarriage or infertility and again found no benefit of levothyroxine supplementation.”
BackgroundGarmendia, J. V., Sanctis, C. V. D., Hajdúch, M., & Sanctis, J. B. D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031295 · Cited by 79
“In two randomized controlled trials, the use of levothyroxine in euthyroid women with thyroid peroxidase antibodies did not result in a higher rate of live births compared to a placebo [217,218].”
Luo, J., Wang, X., Li, Y., & Guo, L. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.629831 · Cited by 69
Dhillon-Smith, R. K., Tobias, A., Smith, P. P., Middleton, L. J., Sunner, K. K., Baker, K., Farrell-Carver, S., Bender-Atik, R., Agrawal, R., Bhatia, K., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa302 · Cited by 67
Self-citationBliddal, S., Feldt-Rasmussen, U., Rasmussen, Å. K., Kolte, A. M., Hilsted, L. M., Christiansen, O. B., Nielsen, C. H., & Nielsen, H. S. (2019) · Thyroid® · doi:10.1089/thy.2019.0077 · Cited by 63
Maternal thyroid disease and its effects on the fetus and perinatal outcomes
Huget‐Penner, S., & Feig, D. S. (2020) · Prenatal Diagnosis · doi:10.1002/pd.5684 · Cited by 61
“There was no difference in live birth rates, pregnancy loss, preterm birth, or neonatal outcomes.(63) Another randomized trial of”
BackgroundMethodUse of Thyroid Hormones in Hypothyroid and Euthyroid Patients; the 2019 Italian Survey
Negro, R., Attanasio, R., Nagy, E. V., Papini, E., Perros, P., & Hegedüs, L. (2020) · European Thyroid Journal · doi:10.1159/000502057 · Cited by 52
Effect of antithyroid antibodies on women with recurrent miscarriage: A meta‐analysis
Xie, J., Jiang, L., Sadhukhan, A., Yang, S., Yao, Q., Zhou, P., Rao, J., & Jin, M. (2020) · American Journal of Reproductive Immunology · doi:10.1111/aji.13238 · Cited by 57
Management of overt hypothyroidism during pregnancy
Li, S. W., & Chan, S. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101439 · Cited by 49
Self-citationUniversal screening for thyroid disease during pregnancy should be performed
Stagnaro‐Green, A., Dong, A. C., & Stephenson, M. D. (2019) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2019.101320 · Cited by 60
Korevaar, T. I. M., Leung, A. M., Alexander, E. K., Bliddal, S., Boelaert, K., Brenta, G., Chou, R., Dhillon‐Smith, R. K., Dosiou, C., Eaton, J. L., et al. (2026) · Thyroid · doi:10.1177/10507256261445624 · Cited by 61
Self-citationDing, Z., Liu, Y., Maraka, S., Abdelouahab, N., Huang, H., Fraser, W. D., & Fan, J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.797423 · Cited by 48
“org 6 among euthyroid pregnant women with TPOAb+ status (12, 28).”
BackgroundEvaluation of Recurrent Pregnancy Loss
de Assis, V., Schenone, C. V., & Ros, S. T. (2024) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005498 · Cited by 51
Subclinical hypothyroidism in pregnancy: controversies on diagnosis and treatment
Gietka‐Czernel, M., & Glinicki, P. (2020) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.15626 · Cited by 46
“No conclusion on the rate of pregnancy loss DhillonSmith et al.,2019 [74] Prospective, randomized double-blind placebocontrolled TSH>2.5-3.6 mU/l Preconception period No beneficial effect of treatment on the rate of live-birth, pregnancy loss, preterm delivery, or in neonatal outcomes Population…”
BackgroundInfluentialMascarenhas, M., Jeve, Y. B., Polański, Ł., Sharpe, A., Yasmin, E., & Bhandari, H. M. (2021) · Human Fertility · doi:10.1080/14647273.2021.1905886 · Cited by 46
“A recent multi-centre RCT found no benefit of commencing preconceptional thyroxine treatment in euthyroid women with thyroid autoimmunity (Dhillon-Smith et al., 2019); there are no studies that relate specifically to RIF.”
BackgroundThyroid Disease in Pregnancy: A Descriptive Review of Guidelines
Tsakiridis, I. G., Giouleka, S., Kourtis, A., Mamopoulos, A. M., Athanasiadis, A. P., & Dagklis, T. (2022) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000960 · Cited by 46
Sankoda, A., Suzuki, H., Imaizumi, M., Yoshihara, A., Kobayashi, S., Katai, M., Hamada, K., Hidaka, Y., Yoshihara, A., Nakamura, H. M., et al. (2024) · Thyroid · doi:10.1089/thy.2023.0546 · Cited by 48
“8,9 In the sensitivity analysis to exclude the study with high risk in other biases, 18 the effect on live birth was significantly different between the subgroups with TSH levels of 2.5–4.0 and > 4.0 mU/L ( I 2 = 80.5%, p = 0.02).”
InfluentialAkhtar, M. A., Agrawal, R., Brown, J., Sajjad, Y., & Craciunas, L. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011009.pub2 · Cited by 55
“Busnelli 2016 Systematic review De Brucker 2016 Not randomised Dhillon-Smith 2019 Heterogeneous population of IVF and other fertility treatments or spontaneous conceptions after recurrent miscarriage Maraka 2016 Study not related to ART Mintziori 2016 Review Mumuşoğlu 2016 Cohort study Nazarpour…”
BackgroundMethodInfluentialSelf-citationTaylor, P. N., & Lazarus, J. H. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.05.010 · Cited by 49
Gill, S., Cheed, V., Morton, V. H., Gill, D., Boelaert, K., Chan, S., Coomarasamy, A., & Dhillon‐Smith, R. K. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac525 · Cited by 40
Self-citationWang, X., Zhang, Y., Tan, H., Bai, Y., Zhou, L., Fang, F., Faramand, A. M., Chong, W., & Hai, Y. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.06.034 · Cited by 36
Holt-Kentwell, A., Ghosh, J., Devall, A., Coomarasamy, A., & Dhillon‐Smith, R. K. (2022) · Human Reproduction Update · doi:10.1093/humupd/dmac001 · Cited by 36
Self-citationSun, X., Hou, N., Wang, H., Ma, L., Sun, J., & Liu, Y. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz217 · Cited by 34
Bednarczuk, T., Attanasio, R., Hegedüs, L., Nagy, E. V., Negro, R., Papini, E., Perros, P., & Ruchała, M. (2021) · Endokrynologia Polska · doi:10.5603/ep.a2021.0048 · Cited by 33
“4%) would consider LT4 treatment in euthyroid females with chronic autoimmune thyroiditis and infertility [25, 26].”
BackgroundWilliamson, C., & Scott, R. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780198851899.003.0005 · Cited by 32
Management of Thyroid Disorders in Pregnancy: Green‐top Guideline No. 76
Chan, S., Marsh, M. S., Gilbert, J., Boelaert, K., Evans, C., & Dhillon‐Smith, R. K. (2025) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.18088 · Cited by 39
Self-citationSubclinical hypothyroidism in pregnancy
Toloza, F. J. K., Abedzadeh-Anaraki, S., & Maraka, S. (2019) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000491 · Cited by 30
Indications for treatment of subclinical hypothyroidism and isolated hypothyroxinaemia in pregnancy
Taylor, P. N., Muller, I., Nana, M., Velasco, I., & Lazarus, J. H. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101436 · Cited by 30
The exploration of Hashimoto's Thyroiditis related miscarriage for better treatment modalities
Min, Y., Wang, X., Chen, H., & Yin, G. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.48128 · Cited by 31
“[22] concluded that there was no significant difference in the live birth rate between the group of TPOAb-positive euthyroid women who received L-T4 tablets (50 μg/d) for six months and the group of TPOAb-positive euthyroid women who were treated with placebo alone.”
BackgroundAhn, H. Y., & Yi, K. H. (2023) · Endocrinology and Metabolism · doi:10.3803/enm.2023.1696 · Cited by 31
Niculescu, D. (2020) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2020.462 · Cited by 28
“This apparently common clinical approach is concerning given the lack of efficacy of LT4 treatment for these clinical problems, which is now well established (19,20).”
BackgroundThyroid hormone therapy of hypothyroidism in pregnancy
Shan, Z., & Teng, W. (2019) · Endocrine · doi:10.1007/s12020-019-02044-2 · Cited by 28
Lau, L. W., Benham, J. L., Lemieux, P., Yamamoto, J. M., & Donovan, L. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-043751 · Cited by 29
Turning to Thyroid Disease in Pregnant Women
Andersen, S. L., & Andersen, S. (2020) · European Thyroid Journal · doi:10.1159/000506228 · Cited by 28
Meems, M., Hulsbosch, L. P., Riem, M. M. E., Meyers, C., Pronk, T., Broeren, M. A. C., Nabbe, K. C., Oei, S. G., Bogaerts, S., & Pop, V. J. M. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-038891 · Cited by 29
Dong, A. C., Stephenson, M. D., & Stagnaro‐Green, A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00193 · Cited by 26
Vardarli, I., Brandenburg, T., Hegedűs, L. D., Attanasio, R., Nagy, E. V., Papini, E., Perros, P., Weidemann, F., Herrmann, K., & Führer, D. (2022) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1832-0644 · Cited by 27
“The rationale being to secure eu thyroidism in case of pregnancy, although LT4 treatment neither promotes conception nor reduces the risk of pregnancy complica tions in such individuals [38, 39].”
BackgroundHubalewska–Dydejczyk, A., Trofimiuk–Müldner, M., Ruchała, M., Lewiñski, A., Bednarczuk, T., Zgliczyński, W., Syrenicz, A., Kos‐Kudła, B., Jarząb, B., Gietka‐Czernel, M., et al. (2021) · Endokrynologia Polska · doi:10.5603/ep.a2021.0089 · Cited by 29
“in particular subgroups of patients with regard to their age, TSH and aTPO antibody concentrations, body mass index, history of obstetric failure, and subfertility treatment [100, 134].”
BackgroundInfluentialPlanck, T., Lantz, M., Perros, P., Papini, E., Attanasio, R., Nagy, E. V., & Hegedüs, L. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.795111 · Cited by 23
“The rationale is to secure euthyroidism in case of pregnancy, although current evidence from randomized trials (38, 39) suggests that L-T4 treatment neither increases fertility rates nor reduces the risk of adverse pregnancy outcomes in these individuals.”
ResultThyroid autoimmunity and pregnancy in euthyroid women
Kyrilli, A., Unuane, D., & Poppe, K. G. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101632 · Cited by 28
“The other study was a multicentre double-blind, placebo-controlled trial by Dhillon-Smith, in which 50 ug LT4 was started before pregnancy in euthyroid women (TSH levels 3.6 mU/L) with TAI and a history of infertility or miscarriage [49,50].”
InfluentialThyroid autoimmunity and adverse pregnancy outcomes: A multiple center retrospective study
Xu, Y., Chen, H., Ren, M., Gao, Y., Sun, K., Wu, H., Ding, R., Wang, J., Li, Z., Liu, D., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1081851 · Cited by 33
“As biologically active hormone, FT3 was not elevated sync with FT4 maybe the potential reasons that levothyroxine supplement did not improve pregnancy outcomes in TAI women in previous study (11, 12).”
BackgroundResultYamamoto, J. M., Metcalfe, A., Nerenberg, K. A., Khurana, R., Chin, A., & Donovan, L. (2020) · Canadian Medical Association Journal · doi:10.1503/cmaj.191664 · Cited by 23
Cut-offs for thyroid peroxidase and thyroglobulin antibodies in early pregnancy
Andersen, S. L., Bruun, N. H., Christensen, P. A., Lykkeboe, S., Handberg, A., Hansen, A. B., Lundgaard, M. H., Knøsgaard, L., Torp, N. M. U., Carlé, A., et al. (2022) · European Thyroid Journal · doi:10.1530/etj-22-0142 · Cited by 25
The influence of thyroid autoimmunity on pregnancy outcome in infertile women: a prospective study
Inagaki, Y., Takeshima, K., Nishi, M., Ariyasu, H., Doi, A., Kurimoto, C., Uraki, S., Morita, S., Furukawa, Y., Inaba, H., et al. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej19-0604 · Cited by 28
Manning, R., Iyer, J., Bulmer, J. N., Maheshwari, A., & Choudhary, M. K. (2020) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2020.1803241 · Cited by 26
“2011), it is interesting that the outcome of the multicentre TABLET RCT was that levothyroxine did not improve live birth rates in euthyroid thyroid peroxidase antibody positive women (Dhillon-Smith et al. 2019).”
BackgroundTóth, B., Bohlmann, M. K., Hancke, K., Kuon, R., Nawroth, F., von Otte, S., Rogenhofer, N., Rudnik‐Schöneborn, S., Schleußner, E., Tempfer, C., et al. (2022) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-1895-9940 · Cited by 26
“This is supported by double-blinded, placebo-controlled, randomized controlled study, in which 952 euthyroid women with prior miscarriage or infertility and confirmed higher levels of TPO Ab received either 50 µg levothyroxine or placebo [66].”
BackgroundMethodWang, J., Liao, X.-X., & Li, T. (2021) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2021-0001 · Cited by 22
“[16, 57] We also need more multi-center clinical randomized trials to further clarify the intervention effect of thyroid hormone on spontaneous abortion, such as TABLET study[58] and T4-LIFE study.”
BackgroundLago, A. D., Galanti, F., Miriello, D., Marcoccia, A., Massimiani, M., Campagnolo, L., Moretti, C., & Rago, R. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10102105 · Cited by 24
“A recent multicenter, randomized, placebo-controlled study showed that, among TAI women, the use of LT4 did not result in a higher rate of live birth compared to placebo, nor it showed a significant between-group difference in other pregnancy outcomes, including pregnancy loss [30].”
BackgroundGalofré, J. C., Attanasio, R., Hegedűs, L. D., Nagy, E. V., Negro, R., Papini, E., Perros, P., & Díez, J. J. (2021) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2021.07.003 · Cited by 25
Endometriosis, polycystic ovary syndrome, and the thyroid: a review
Kirkegaard, S. S., Torp, N. M. U., Andersen, S., & Andersen, S. L. (2023) · Endocrine Connections · doi:10.1530/ec-23-0431 · Cited by 32
“A link between thyroid disease and infertility as well as early pregnancy complications has been established; however, uncertainties prevail regarding the underlying mechanisms for the associations observed and as to whether thyroid function and/or autoimmunity is the key determinant (8, 9, 10, 11).”
BackgroundPlacental pathologic features in thyroid autoimmunity
Spinillo, A., Maggio, I. D., Ruspini, B., Bellingeri, C., Cavagnoli, C., Giannico, S., Boschetti, A., Magri, F., Lovati, E., & Beneventi, F. (2021) · Placenta · doi:10.1016/j.placenta.2021.07.287 · Cited by 21
Classification of maternal thyroid function in early pregnancy using repeated blood samples
Knøsgaard, L., Andersen, S., Hansen, A. B., Vestergaard, P., & Andersen, S. L. (2022) · European Thyroid Journal · doi:10.1530/etj-21-0055 · Cited by 21
Burlacu, M.-C., Attanasio, R., Hegedüs, L., Nagy, E. V., Papini, E., Perros, P., Sawadogo, K., Bex, M., Corvilain, B., Daumerie, C., et al. (2022) · Thyroid Research · doi:10.1186/s13044-022-00121-9 · Cited by 19
“or receiving treatment for infertility [23].”
Rao, M., Zeng, Z., Zhang, Q., Su, C., Yang, Z., Zhao, S., & Tang, L. (2022) · Thyroid · doi:10.1089/thy.2022.0184 · Cited by 21
“3,12 Moreover, two randomized controlled trials, namely, the TABLET and POSTAL trials, that were published in 2019 13,14 reported no beneficial effects of levothyroxine (LT4) treatment on the clinical pregnancy rate (CPR) or live birth rate (LBR) and no reduction in pregnancy loss in eu-thyroid…”
Nattero‐Chávez, L., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.04.039 · Cited by 20
Leduc-Robert, G., Iews, M., Abdelkareem, A. O., Williams, C., Bloomenthal, D., AbdelHafez, F. F., & Bedaiwy, M. A. (2019) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2019.11.014 · Cited by 22
Girolamo, R. D., Liberati, M., Silvi, C., & D’Antonio, F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.759064 · Cited by 22
Endocrine Autoimmunity in Pregnancy
Świątkowska−Stodulska, R., Berlińska, A., Stefanska, K. A., Zieliński, M., Kwiatkowski, S., Połom, J., Andrysiak-Mamos, E., Wydra, P., & Sworczak, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.907561 · Cited by 20
Younes, Y. R., Perros, P., Hegedüs, L., Papini, E., Nagy, E. V., Attanasio, R., Negro, R., & Field, B. C. T. (2023) · Clinical Endocrinology · doi:10.1111/cen.14812 · Cited by 19
Update on therapeutic use of levothyroxine for the management of hypothyroidism during pregnancy
Urgatz, B., & Poppe, K. G. (2024) · Endocrine Connections · doi:10.1530/ec-23-0420 · Cited by 21
“The recent guidance from the RCOG included consideration of one of the recent randomised trials in euthyroid, TPOAb+ women (45) and recommended that LT4 should not be given in this setting (9).”
BackgroundMethodRecurrent pregnancy loss: a committee opinion
Gracia, C. R., Amato, P., Anderson, J., Flyckt, R. L., Hansen, K., Hill, M., Jain, T., Jindal, S., Kalra, S., Pier, B. D., et al. (2026) · Fertility and Sterility · doi:10.1016/j.fertnstert.2026.03.001 · Cited by 27
Provinciatto, H. G., Moreira, M. V. B., Neves, G. R., de Freitas, L. R., Mitsui, H. C., Zhang, J. M. F., & Júnior, E. A. (2024) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-024-07512-3 · Cited by 19
Huang, S., Ziros, P. G., Chartoumpekis, D. V., Psarias, G., Duntas, L. H., Zuo, X., Li, X., Ding, Z., & Sykiotis, G. P. (2024) · Antioxidants · doi:10.3390/antiox13070868 · Cited by 17
Pajzsmirigyhormon-kezelési szokások Magyarországon.: A THESIS kérdőíves felmérés eredményei
Berta, E., Lengyel, I. M., Hegedűs, L., Papini, E., Perros, P., Negro, R., Attanasio, R., Nagy, V. E., & Bodor, M. (2022) · Orvosi Hetilap · doi:10.1556/650.2022.32412 · Cited by 17
“[25] Dhillon-Smith RK, Middleton LJ, Sunner KK, et al.”
Interventions to prevent miscarriage
Dhillon‐Smith, R. K., Melo, P., Kaur, R., Fox, E., Devall, A., Woodhead, N., & Coomarasamy, A. (2023) · Fertility and Sterility · doi:10.1016/j.fertnstert.2023.08.955 · Cited by 20
Self-citationDhillon‐Smith, R. K., Boelaert, K., Jeve, Y. B., Maheshwari, A., Coomarasamy, A., & Royal College of Obstetricians and Gynaecologists (2022) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17187 · Cited by 16
Self-citationThe maternal drug exposure birth cohort (DEBC) in China
Li, L., Wang, K., Wang, M., Tao, J., Li, X., Liu, Z., Li, N., Qiu, X., Wei, H., Lin, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49623-0 · Cited by 16
Toloza, F. J. K., Theriot, S. E., Ospina, N. S., Nooruddin, S., Keathley, B., Johnson, S. M., Payakachat, N., Ambrogini, E., Rodríguez‐Gutiérrez, R., O'Keeffe, D. T., et al. (2020) · Thyroid · doi:10.1089/thy.2020.0629 · Cited by 18
Turunen, S., Vääräsmäki, M., Leinonen, M. K., Gissler, M., Männistö, T. I., & Suvanto, E. T. J. (2021) · European Thyroid Journal · doi:10.1159/000515125 · Cited by 18
Jiskra, J., Paleček, J., Attanasio, R., Hegedüs, L., Nagy, E. V., Papini, E., Perros, P., Negro, R., & Kršek, M. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01027-1 · Cited by 14
“However, at variance with earlier studies [33], the recent large studies found that LT4 intervention had no impact on the rate of miscarriage, preterm delivery, and live births in euthyroid thyroid antibody positive women [34, 35].”
ResultLevothyroxine and subclinical hypothyroidism in patients with recurrent pregnancy loss
Yoshihara, H., Sugiura‐Ogasawara, M., Goto, S., & Kitaori, T. (2020) · American Journal of Reproductive Immunology · doi:10.1111/aji.13341 · Cited by 14
Hubalewska–Dydejczyk, A., Gietka‐Czernel, M., Trofimiuk–Müldner, M., Zgliczyński, W., Ruchała, M., Lewiñski, A., Bednarczuk, T., Syrenicz, A., Kos‐Kudła, B., Jarząb, B., et al. (2022) · Endokrynologia Polska · doi:10.5603/ep.a2022.0069 · Cited by 20
Reproductive factors and subsequent pregnancy outcomes in patients with prior pregnancy loss
Yang, X., Mu, F., Zhang, J., Yuan, L., Zhang, W., Yang, Y., & Wang, F. (2024) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-024-06422-1 · Cited by 15
“However, levothyroxine did not improve pregnancy outcomes in patients with subclinical hypothyroidism [34].”
BackgroundNegro, R. (2019) · Thyroid Research · doi:10.1186/s13044-019-0066-0 · Cited by 13
Metadata
- Authors
- Dhillon-Smith, R. K., Middleton, L. J., Sunner, K. K., Cheed, V., Baker, K., Farrell-Carver, S., Bender-Atik, R., Agrawal, R., Bhatia, K., Edi-Osagie, E., Ghobara, T., Gupta, P., Jurkovic, D., Khalaf, Y., MacLean, M., McCabe, C., Mulbagal, K., Nunes, N., Overton, C., Quenby, S., Rai, R., Raine-Fenning, N., Robinson, L., Ross, J., Sizer, A., Small, R., Tan, A., Underwood, M., Kilby, M. D., Boelaert, K., Daniels, J., Thangaratinam, S., Chan, S. Y., & Coomarasamy, A.
- Affiliations
- From the Institute of Metabolism and Systems Research (R.K.D.-S., C.M., M.D.K., K. Boelaert, A.C.), Tommy’s National Centre for Miscarriage Research (R.K.D.-S., A.C.), and the Birmingham Clinical Trials Unit, Institute of Applied Health Research (L.J.M., K.K.S., V.C., S.F.-C.), College of Medical and Dental Sciences, University of Birmingham, the Birmingham Women’s and Children’s NHS Foundation Trust (R.K.D.-S., L.R., M.D.K., A.C.), and University Hospital Birmingham (P.G., R.S.), Birmingham, the...
- Cancer Research UK Clinical Trials Unit (GB)
- University of Oxford (GB)
- Miscarriage Association (GB)
- University Hospital Coventry (GB)
- Burnley General Teaching Hospital (GB)
- St Mary's Hospital (GB)
- Birmingham Women’s and Children’s NHS Foundation Trust (GB)
- University College Hospital (GB)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- University Hospital Crosshouse (GB)
- Bolton NHS Foundation Trust (GB)
- Chelsea and Westminster Hospital NHS Foundation Trust (GB)
- University Hospitals Bristol NHS Foundation Trust (GB)
- Imperial College Healthcare NHS Trust (GB)
- King's College Hospital NHS Foundation Trust (GB)
- Shrewsbury and Telford Hospital NHS Trust (GB)
- Queen Mary University of London (GB)
- University of Nottingham (GB)
- National University of Singapore (SG)
- ORCID
- Middleton, Lee J.
- Sunner, Kirandeep K.
- Cheed, Versha
- Baker, Krys
- Farrell-Carver, Samantha
- Bender-Atik, Ruth
- Agrawal, Rina
- Bhatia, Kalsang
- Edi-Osagie, Edmond
- Ghobara, Tarek
- Gupta, Pratima
- Jurkovic, Davor
- Khalaf, Yacoub
- MacLean, Marjory
- McCabe, Christopher
- Mulbagal, Khashia
- Nunes, Natalie
- Overton, Caroline
- Quenby, Siobhan
- Ross, Jackie
- Sizer, Andrew
- Small, Rachel
- Tan, Alex
- Underwood, Martyn
- Kilby, Mark D.
- Boelaert, Kristien
- Daniels, Jane
- Thangaratinam, Shakila
- Chan, Shiao Y.
- Coomarasamy, Arri
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2019-04-04
- Volume
- 380
- Issue
- 14
- Pages
- 1316-1325
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2925290838
- Cited by
- 303
- References
- 6
- Citations by year
- 2026: 20 · 2025: 21 · 2024: 35 · 2023: 45 · 2022: 65 · 2021: 40 · 2020: 50 · 2019: 27
- FWCI
- 36.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- New England Journal of Medicine (publishedVersion, other-oa)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (publishedVersion, other-oa)
- Bristol Research (University of Bristol) (publishedVersion, other-oa)
- Warwick Research Archive Portal (University of Warwick) (acceptedVersion)
- Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by)
- Funders
- Efficacy and Mechanism Evaluation Programme (09/100/10)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Keywords
- levothyroxine, thyroid peroxidase antibodies, thyroid autoantibodies, live birth rate, miscarriage, preterm birth, infertility, pregnancy outcomes, euthyroid women, adverse drug reactions
- MeSH terms
- Abortion, Spontaneous, Adult, Autoantibodies, Double-Blind Method, Female, Humans, Infertility, Female, Iodide Peroxidase, Pregnancy, Thyrotropin, Thyroxine, Preconception Care, Treatment Failure, Live Birth
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.